DCF Advisers’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-10,000
| Closed | -$93.7K | – | 84 |
|
|
2023
Q3 | $93.7K | Sell |
10,000
-45,000
| -82% | -$422K | 0.05% | 73 |
|
|
2023
Q2 | $1.35M | Sell |
55,000
-7,000
| -11% | -$172K | 0.71% | 30 |
|
|
2023
Q1 | $1.44M | Buy |
62,000
+38,000
| +158% | +$884K | 0.88% | 28 |
|
|
2022
Q4 | $607K | Buy |
+24,000
| New | +$607K | 0.41% | 38 |
|
|
2022
Q1 | – | Sell |
-20,000
| Closed | -$837K | – | 75 |
|
|
2021
Q4 | $837K | Sell |
20,000
-8,000
| -29% | -$335K | 0.34% | 44 |
|
|
2021
Q3 | $1.22M | Buy |
28,000
+15,929
| +132% | +$693K | 0.54% | 38 |
|
|
2021
Q2 | $571K | Buy |
12,071
+4,879
| +68% | +$231K | 0.2% | 53 |
|
|
2021
Q1 | $369K | Sell |
7,192
-13,808
| -66% | -$708K | 0.16% | 68 |
|
|
2020
Q4 | $562K | Sell |
21,000
-5,000
| -19% | -$134K | 0.23% | 53 |
|
|
2020
Q3 | $893K | Buy |
26,000
+18,500
| +247% | +$635K | 0.46% | 43 |
|
|
2020
Q2 | $307K | Buy |
+7,500
| New | +$307K | 0.17% | 53 |
|